News | RIVM

Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination

Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.

Vaccination against meningococcal disease starts for teens aged 14 to 18

This spring, about 860,000 young people in the Netherlands will receive an invitation for a vaccination against meningococcal disease.

Vaccination schedule for babies reviewed after introduction whooping cough vaccination for pregnant women

Whooping cough is a dangerous disease for new born, unvaccinated babies. Starting at the end of 2019, the whooping cough vaccination will be offered nationwide to pregnant women.

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

Teen vaccination against meningococcal disease starts

From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

Chance of ESBL contamination via livestock farming is small

ESBL is an enzyme, produced by certain bacteria, which makes these bacteria resistant to antibiotics.

European critical loads: database, biodiversity and ecosystems at risk

Approximately 79 percent of the nature reserves (Natura 2000 areas) in EU countries are estimated to be exposed to an excess of nitrogen deposition in 2020.

Meningococcal immunisation recommendations re-examined

Meningococcal disease is a very serious infectious disease that can cause meningitis or blood poisoning. Children are immunised against meningococcal serogroup C at 14 months.

Bacteria slightly more often resistant to last resort antibiotics

Antimicrobial resistance is a global problem. In the Netherlands, some bacteria that can cause infections in people are more frequently resistant to antibiotics used as a last resort.